We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+30.6%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$43.1B
AUM Growth
+$3.9B
Cap. Flow
+$196M
Cap. Flow %
0.46%
Top 10 Hldgs %
17.24%
Holding
3,508
New
269
Increased
1,735
Reduced
1,181
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 9.57%
2 Healthcare 9.13%
3 Financials 8.63%
4 Industrials 6.92%
5 Communication Services 6.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFBX
2951
DELISTED
Peoples Financial Corp/MS
PFBX
$171K ﹤0.01%
11,391
-3,535
-24% -$54.1K
ASA
2952
ASA Gold and Precious Metals
ASA
$1.09B
$170K ﹤0.01%
14,072
-692
-5% -$8.51K
GDS icon
2953
GDS Holdings
GDS
$6.41B
$169K ﹤0.01%
20,443
+4,274
+26% +$34.9K
TWX
2954
CALL
DELISTED
Time Warner Inc
TWX
$169K ﹤0.01%
49,700
-8,500
-15% -$823K
MRK icon
2955
CALL
Merck
MRK
$318B
$168K ﹤0.01%
110,564
+3,773
+4% +$229K
NXJ
2956
DELISTED
Nuveen New Jersey Quality Municipal Income Fund
NXJ
$167K ﹤0.01%
12,552
+531
+4% +$7.04K
CVU icon
2957
CPI Aerostructures
CVU
$68.5M
$166K ﹤0.01%
+24,600
New +$195K
MACK
2958
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$166K ﹤0.01%
6,835
+1,209
+21% +$30.2K
ACTG icon
2959
Acacia Research
ACTG
$470M
$165K ﹤0.01%
28,640
-1,800
-6% -$10.5K
MDT icon
2960
CALL
Medtronic
MDT
$112B
$163K ﹤0.01%
75,200
-800
-1% -$62.5K
CMCSA icon
2961
CALL
Comcast
CMCSA
$90B
$162K ﹤0.01%
40,400
-600
-1% -$22.3K
PHD
2962
DELISTED
Pioneer Floating Rate Fund
PHD
$162K ﹤0.01%
13,262
+169
+1% +$2.06K
IMUX icon
2963
Immunic
IMUX
$195M
$161K ﹤0.01%
101
+70
+226% +$128K
MUC icon
2964
BlackRock MuniHoldings California Quality Fund
MUC
$1.01B
$161K ﹤0.01%
11,395
-3,500
-23% -$49.6K
ATEN icon
2965
A10 Networks
ATEN
$1.95B
$160K ﹤0.01%
+17,455
New +$154K
INVA icon
2966
Innoviva
INVA
$1.48B
$160K ﹤0.01%
+11,546
New +$136K
PCM
2967
PCM Fund
PCM
$70.1M
$160K ﹤0.01%
15,774
+25
+0.2% +$255
TRIB
2968
Trinity Biotech
TRIB
$8.39M
$160K ﹤0.01%
179
-7
-4% -$6.57K
VFL
2969
DELISTED
abrdn National Municipal Income Fund
VFL
$160K ﹤0.01%
12,362
EMF
2970
Templeton Emerging Markets Fund
EMF
$326M
$158K ﹤0.01%
11,254
-17,110
-60% -$227K
BKK
2971
DELISTED
Blackrock Municipal 2020 Term Trust
BKK
$158K ﹤0.01%
10,017
-6,845
-41% -$107K
FUND
2972
Sprott Focus Trust
FUND
$308M
$157K ﹤0.01%
21,109
+23
+0.1% +$169
NCV
2973
Virtus Convertible & Income Fund
NCV
$390M
$157K ﹤0.01%
5,818
-426
-7% -$11.4K
ERF
2974
DELISTED
Enerplus Corporation
ERF
$157K ﹤0.01%
19,562
+1,754
+10% +$15.4K
ASNA
2975
DELISTED
Ascena Retail Group, Inc.
ASNA
$157K ﹤0.01%
1,842

Similar funds

Raymond James & Associates's Q1 2017 Portfolio in Review

As of Q1 2017, Raymond James & Associates held 3,508 positions worth $43.1B, up 10% from $39.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Raymond James & Associates's Q1 2017 filing shows 269 new, 1,735 increased, 1,181 reduced and 217 closed positions. Its largest new stake was iShares Global REIT ETF: 2,916,742 shares worth $73.9M. The largest sale was TotalEnergies, an estimated $1.85B.

By sector, the portfolio is most concentrated in Technology at 9.6% of assets, up from 9.2% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q1 2017 buy was iShares Global REIT ETF: 2,916,742 shares worth $73.9M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2017, an estimated $997M increase.
  • Raymond James & Associates's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $1.85B.
  • Raymond James & Associates fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $23.6M.
  • Raymond James & Associates's ten largest holdings make up 17% of its $43.1B portfolio in Q1 2017.
  • Raymond James & Associates opened 269 new positions and closed 217 in Q1 2017.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $43.1B.

Based on Raymond James & Associates's 13F filing for Q1 2017, filed 15 May 2017.